Kathleen Tenner

<i>HER2</i> and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial

Edith A. Perez, Monica M. Reinholz, David W. Hillman et al. · Journal of Clinical Oncology · 2010 · 231 citations · Full text

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)

Michael Gnant, Amylou C. Dueck, Sophie Frantal et al. · Journal of Clinical Oncology · 2021 · 220 citations · Full text

Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial

Edith A. Perez, E. Aubrey Thompson, Karla V. Ballman et al. · Journal of Clinical Oncology · 2015 · 200 citations · Full text

Change in Pattern of <i>HER2</i> Fluorescent in Situ Hybridization (FISH) Results in Breast Cancers Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists Guidelines

Mithun Vinod Shah, Anne E. Wiktor, Reid G. Meyer et al. · Journal of Clinical Oncology · 2016 · 85 citations

Breast Oncology, Pathology, Dermatology +18

Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria

Edith A. Perez, Amylou C. Dueck, Ann E. McCullough et al. · JNCI Journal of the National Cancer Institute · 2011 · 78 citations · Full text

Breast Oncology, Cancer Management, Immunology +19